UniProt ID | ARGI1_MOUSE | |
---|---|---|
UniProt AC | Q61176 | |
Protein Name | Arginase-1 | |
Gene Name | Arg1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 323 | |
Subcellular Localization | Cytoplasm . Cytoplasmic granule . | |
Protein Description | Key element of the urea cycle converting L-arginine to urea and L-ornithine, which is further metabolized into metabolites proline and polyamides that drive collagen synthesis and bioenergetic pathways critical for cell proliferation, respectively; the urea cycle takes place primarily in the liver and, to a lesser extent, in the kidneys.; Functions in L-arginine homeostasis in nonhepatic tissues characterized by the competition between nitric oxide synthase (NOS) and arginase for the available intracellular substrate arginine. Arginine metabolism is a critical regulator of innate and adaptive immune responses. Involved in an antimicrobial effector pathway in polymorphonuclear granulocytes (PMN). Upon PMN cell death is liberated from the phagolysosome and depletes arginine in the microenvironment leading to suppressed T cell and natural killer (NK) cell proliferation and cytokine secretion (By similarity). In group 2 innate lymphoid cells (ILC2s) promotes acute type 2 inflammation in the lung and is involved in optimal ILC2 proliferation but not survival. [PubMed: 27043409 Plays a role in the immune response of alternatively activated or M2 macrophages in processes such as wound healing and tissue regeneration, immune defense against multicellular pathogens and parasites, and immune suppression and allergic inflammation; the regulatory outcome seems to be organ specific] | |
Protein Sequence | MSSKPKSLEIIGAPFSKGQPRGGVEKGPAALRKAGLLEKLKETEYDVRDHGDLAFVDVPNDSSFQIVKNPRSVGKANEELAGVVAEVQKNGRVSVVLGGDHSLAVGSISGHARVHPDLCVIWVDAHTDINTPLTTSSGNLHGQPVSFLLKELKGKFPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYIIKTLGIKYFSMTEVDKLGIGKVMEETFSYLLGRKKRPIHLSFDVDGLDPAFTPATGTPVLGGLSYREGLYITEEIYKTGLLSGLDIMEVNPTLGKTAEEVKSTVNTAVALTLACFGTQREGNHKPGTDYLKPPK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSSKPKSLE ------CCCCCCCEE | 47.25 | 24719451 | |
3 | Phosphorylation | -----MSSKPKSLEI -----CCCCCCCEEE | 52.24 | 17242355 | |
6 | Malonylation | --MSSKPKSLEIIGA --CCCCCCCEEECCC | 71.99 | 26320211 | |
6 | Ubiquitination | --MSSKPKSLEIIGA --CCCCCCCEEECCC | 71.99 | - | |
6 | Acetylation | --MSSKPKSLEIIGA --CCCCCCCEEECCC | 71.99 | 23954790 | |
7 | Phosphorylation | -MSSKPKSLEIIGAP -CCCCCCCEEECCCC | 39.50 | 25521595 | |
16 | Phosphorylation | EIIGAPFSKGQPRGG EECCCCCCCCCCCCC | 34.51 | 29472430 | |
17 | Ubiquitination | IIGAPFSKGQPRGGV ECCCCCCCCCCCCCC | 63.04 | 27667366 | |
17 | Acetylation | IIGAPFSKGQPRGGV ECCCCCCCCCCCCCC | 63.04 | 23954790 | |
17 | Succinylation | IIGAPFSKGQPRGGV ECCCCCCCCCCCCCC | 63.04 | 23806337 | |
17 | Malonylation | IIGAPFSKGQPRGGV ECCCCCCCCCCCCCC | 63.04 | 26320211 | |
17 | Succinylation | IIGAPFSKGQPRGGV ECCCCCCCCCCCCCC | 63.04 | - | |
26 | Malonylation | QPRGGVEKGPAALRK CCCCCCCCCHHHHHH | 68.72 | 26320211 | |
26 | Acetylation | QPRGGVEKGPAALRK CCCCCCCCCHHHHHH | 68.72 | 23864654 | |
26 | Ubiquitination | QPRGGVEKGPAALRK CCCCCCCCCHHHHHH | 68.72 | 27667366 | |
33 | Malonylation | KGPAALRKAGLLEKL CCHHHHHHCCHHHHH | 47.89 | 26320211 | |
39 | Malonylation | RKAGLLEKLKETEYD HHCCHHHHHHHCCCC | 65.90 | 26320211 | |
39 | Ubiquitination | RKAGLLEKLKETEYD HHCCHHHHHHHCCCC | 65.90 | 27667366 | |
39 | Acetylation | RKAGLLEKLKETEYD HHCCHHHHHHHCCCC | 65.90 | 23864654 | |
39 | Succinylation | RKAGLLEKLKETEYD HHCCHHHHHHHCCCC | 65.90 | - | |
41 | Ubiquitination | AGLLEKLKETEYDVR CCHHHHHHHCCCCCC | 73.91 | 27667366 | |
41 | Malonylation | AGLLEKLKETEYDVR CCHHHHHHHCCCCCC | 73.91 | 26073543 | |
41 | Acetylation | AGLLEKLKETEYDVR CCHHHHHHHCCCCCC | 73.91 | 23954790 | |
41 | Glutarylation | AGLLEKLKETEYDVR CCHHHHHHHCCCCCC | 73.91 | 24703693 | |
41 | Succinylation | AGLLEKLKETEYDVR CCHHHHHHHCCCCCC | 73.91 | - | |
62 | Phosphorylation | FVDVPNDSSFQIVKN EEECCCCCCEEEECC | 39.43 | 25521595 | |
63 | Phosphorylation | VDVPNDSSFQIVKNP EECCCCCCEEEECCC | 24.84 | 25521595 | |
68 | Malonylation | DSSFQIVKNPRSVGK CCCEEEECCCCCCCC | 63.96 | 26320211 | |
68 | Ubiquitination | DSSFQIVKNPRSVGK CCCEEEECCCCCCCC | 63.96 | - | |
68 | Acetylation | DSSFQIVKNPRSVGK CCCEEEECCCCCCCC | 63.96 | 23954790 | |
72 | Phosphorylation | QIVKNPRSVGKANEE EEECCCCCCCCCCHH | 36.16 | 22324799 | |
75 | Acetylation | KNPRSVGKANEELAG CCCCCCCCCCHHHHH | 45.97 | 23806337 | |
75 | Succinylation | KNPRSVGKANEELAG CCCCCCCCCCHHHHH | 45.97 | 23806337 | |
75 | Malonylation | KNPRSVGKANEELAG CCCCCCCCCCHHHHH | 45.97 | 26320211 | |
75 | Succinylation | KNPRSVGKANEELAG CCCCCCCCCCHHHHH | 45.97 | - | |
75 | Ubiquitination | KNPRSVGKANEELAG CCCCCCCCCCHHHHH | 45.97 | 27667366 | |
89 | Malonylation | GVVAEVQKNGRVSVV HHEEEEHHCCEEEEE | 67.55 | 26320211 | |
89 | Acetylation | GVVAEVQKNGRVSVV HHEEEEHHCCEEEEE | 67.55 | 23864654 | |
89 | Ubiquitination | GVVAEVQKNGRVSVV HHEEEEHHCCEEEEE | 67.55 | 27667366 | |
153 | Ubiquitination | SFLLKELKGKFPDVP HHHHHHHCCCCCCCC | 62.23 | 22790023 | |
155 | Malonylation | LLKELKGKFPDVPGF HHHHHCCCCCCCCCC | 52.73 | 26320211 | |
155 | Acetylation | LLKELKGKFPDVPGF HHHHHCCCCCCCCCC | 52.73 | 22733758 | |
155 | Ubiquitination | LLKELKGKFPDVPGF HHHHHCCCCCCCCCC | 52.73 | - | |
163 | Phosphorylation | FPDVPGFSWVTPCIS CCCCCCCCCCCCCCC | 26.93 | 22324799 | |
166 | Phosphorylation | VPGFSWVTPCISAKD CCCCCCCCCCCCHHH | 13.24 | 23140645 | |
168 | S-palmitoylation | GFSWVTPCISAKDIV CCCCCCCCCCHHHEE | 2.54 | 28526873 | |
170 | Phosphorylation | SWVTPCISAKDIVYI CCCCCCCCHHHEEEE | 35.66 | 23140645 | |
172 | Malonylation | VTPCISAKDIVYIGL CCCCCCHHHEEEEEE | 40.99 | 26073543 | |
176 | Phosphorylation | ISAKDIVYIGLRDVD CCHHHEEEEEECCCC | 6.93 | 20531401 | |
191 | Acetylation | PGEHYIIKTLGIKYF CCCCEEEEECCCEEE | 28.30 | 22733758 | |
191 | Ubiquitination | PGEHYIIKTLGIKYF CCCCEEEEECCCEEE | 28.30 | - | |
191 | Malonylation | PGEHYIIKTLGIKYF CCCCEEEEECCCEEE | 28.30 | 26320211 | |
196 | Acetylation | IIKTLGIKYFSMTEV EEEECCCEEEECCCH | 38.14 | 23954790 | |
196 | Ubiquitination | IIKTLGIKYFSMTEV EEEECCCEEEECCCH | 38.14 | 22790023 | |
197 | Phosphorylation | IKTLGIKYFSMTEVD EEECCCEEEECCCHH | 10.04 | 29472430 | |
199 | Phosphorylation | TLGIKYFSMTEVDKL ECCCEEEECCCHHHH | 23.00 | 25521595 | |
201 | Phosphorylation | GIKYFSMTEVDKLGI CCEEEECCCHHHHCH | 31.49 | 25521595 | |
205 | Acetylation | FSMTEVDKLGIGKVM EECCCHHHHCHHHHH | 54.51 | 23954790 | |
205 | Ubiquitination | FSMTEVDKLGIGKVM EECCCHHHHCHHHHH | 54.51 | 27667366 | |
205 | Malonylation | FSMTEVDKLGIGKVM EECCCHHHHCHHHHH | 54.51 | 26320211 | |
215 | Phosphorylation | IGKVMEETFSYLLGR HHHHHHHHHHHHHCC | 12.46 | 23984901 | |
217 | Phosphorylation | KVMEETFSYLLGRKK HHHHHHHHHHHCCCC | 23.45 | 22817900 | |
218 | Phosphorylation | VMEETFSYLLGRKKR HHHHHHHHHHCCCCC | 11.18 | 23984901 | |
224 | Malonylation | SYLLGRKKRPIHLSF HHHHCCCCCCEEEEE | 63.14 | 26320211 | |
230 | Phosphorylation | KKRPIHLSFDVDGLD CCCCEEEEEECCCCC | 12.77 | 17203969 | |
241 | Phosphorylation | DGLDPAFTPATGTPV CCCCCCCCCCCCCCC | 17.70 | - | |
244 | Phosphorylation | DPAFTPATGTPVLGG CCCCCCCCCCCCCCC | 42.67 | 17203969 | |
246 | Phosphorylation | AFTPATGTPVLGGLS CCCCCCCCCCCCCCC | 13.08 | 17203969 | |
265 | Phosphorylation | LYITEEIYKTGLLSG EEECHHHHHCCCCCC | 13.04 | 17242355 | |
281 | Phosphorylation | DIMEVNPTLGKTAEE CEEECCCCCCCCHHH | 42.83 | 25521595 | |
284 | Acetylation | EVNPTLGKTAEEVKS ECCCCCCCCHHHHHH | 47.91 | 22733758 | |
284 | Malonylation | EVNPTLGKTAEEVKS ECCCCCCCCHHHHHH | 47.91 | 26320211 | |
284 | Ubiquitination | EVNPTLGKTAEEVKS ECCCCCCCCHHHHHH | 47.91 | - | |
285 | Phosphorylation | VNPTLGKTAEEVKST CCCCCCCCHHHHHHH | 37.19 | 21082442 | |
290 | Malonylation | GKTAEEVKSTVNTAV CCCHHHHHHHHHHHH | 43.63 | 26320211 | |
303 | S-palmitoylation | AVALTLACFGTQREG HHHHHHHHHCCCCCC | 3.48 | 28526873 | |
313 | Malonylation | TQREGNHKPGTDYLK CCCCCCCCCCCCCCC | 49.49 | 26073543 | |
313 | Acetylation | TQREGNHKPGTDYLK CCCCCCCCCCCCCCC | 49.49 | 23201123 | |
313 | Ubiquitination | TQREGNHKPGTDYLK CCCCCCCCCCCCCCC | 49.49 | 27667366 | |
320 | Malonylation | KPGTDYLKPPK---- CCCCCCCCCCC---- | 53.71 | 26320211 | |
320 | Ubiquitination | KPGTDYLKPPK---- CCCCCCCCCCC---- | 53.71 | 27667366 | |
320 | Acetylation | KPGTDYLKPPK---- CCCCCCCCCCC---- | 53.71 | 23864654 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ARGI1_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARGI1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARGI1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of ARGI1_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3, AND MASSSPECTROMETRY. | |
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-230, AND MASSSPECTROMETRY. |